Sartorius, life science tools

Sartorius Stock - Thursday technicals and volatility picture

18.06.2026 - 18:41:28 | ad-hoc-news.de

Sartorius stock faced another volatile session on Thursday, with shares trading clearly below recent highs and under pressure from ongoing sector rotation in healthcare equipment. A closer look at the chart, volume and 200-day line shows where the technical picture stands.

Sartorius, life science tools, chart and technicals
Sartorius, life science tools, chart and technicals

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:39 CET. Details in the imprint.

Sartorius (DE0007165631) remains under chart pressure on Thursday as the shares continue to trade well below their 2024 peaks. The latest intraday levels point to a soft technical setup for the healthcare equipment group, according to German trading data.

Go deeper

All news and data on Sartorius stock

Background reports, real-time prices and further updates on Sartorius shares can be found in the dedicated topic section and on the company's investor relations pages.

What Thursday's trading shows

On Thursday afternoon, Sartorius preference shares traded around EUR 213 to EUR 214 on Xetra and at EUR 213.60 on the L&S Exchange, implying a decline of roughly 6% versus the previous close according to intraday quote data.

Trading volume on Xetra reached more than 68,000 shares by mid-afternoon, indicating active participation in the stock on a volatile day for German healthcare and industrial names.

Chart levels and 200-day line

The current Xetra quote around EUR 213 sits clearly below the 52-week high, illustrating how far the shares have pulled back from earlier peaks in the German mid-cap space.

According to chart data, Sartorius shares are trading under their 200-day moving average, signaling a cautious technical stance as long as the price remains below this longer-term trend line.

Analyst and sector backdrop

Recent months have seen several analyst houses cut estimates and targets on Sartorius after a weaker demand phase in parts of the bioprocessing market, as reflected in consensus data on financial portals.

The broader European healthcare equipment and life-science tools sector has also experienced valuation pressure, which has weighed on sentiment toward Sartorius alongside company-specific earnings volatility.

The business behind the stock

Sartorius focuses on bioprocess solutions and lab products that help pharmaceutical and biotech companies develop and manufacture biologic drugs, including single-use bioreactors, filtration systems and precision lab instruments for cell culture and analytics.

Where the stock trades today

The shares of Sartorius (DE0007165631) trade on Xetra at EUR 213.40 as of 06/18/2026, 15:23 CET.

Key facts on Sartorius stock

  • Company: Sartorius AG
  • ISIN: DE0007165631
  • WKN: 716563
  • Ticker: SRT3
  • Venue: Xetra
  • Price (as of 06/18/2026, 15:23 CET): 213.40 EUR
  • Market cap: 15,000,000,000 EUR (as of 06/18/2026)
  • Sector / Industry: Industrials / Life science tools & services
  • Index membership: MDAX
  • Next earnings date: not officially scheduled

More on Sartorius stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | boerse | 69574820 |